This week members of Community Oncology gather for their annual conference in Florida. Here's our preview. ajmc.com/view/coa-to-ce…

Axi-Cel Improves Overall Survival vs Standard-of-Care Initial Treatment for R/R LBCL Kite, a Gilead Company #Yescarta ajmc.com/view/axi-cel-i… via ajmc

Kashyap Patel, MD, Sees Link Between #COVID19 and Cancer Progression, Calls for More #biomarker Testing ajmc.com/view/kashyap-p… via ajmc

Off to a great start! #COA2023

BREAKING NEWS: ⁦Senate Finance Cmte⁩ holding hearing 3/30 on #PBM abuses. Panel at #COA2023 now talking #PBMs and their abuses including ⁦Jonathan Levitt⁩ who will be testifying at the hearing.

As Decision Time on #EOM Nears, Lots of Questions From #COA2023 Panel ajmc.com/view/as-decisi… via ajmc

Community Oncology Offers Nimbleness for Pivot to Value-Based Care #COA2023 Community Oncology ajmc.com/view/community… via ajmc

Could This Be the Year for #PBM Reform? #COA2023 Panel Weighs in Community Oncology The US Oncology Network ACCC ajmc.com/view/could-thi… via ajmc

What the heck?

'Live free and die'? The sad state of U.S. life expectancy npr.org/sections/healt…

Delivery Matters: In Early Studies, DPX Technology Allows Vaccines to Persist When Cancer Pushes Back #IMV #DLBCL #ovarian ajmc.com/view/delivery-… via ajmc

.National Comprehensive Cancer Network (NCCN) Session Offers Considerations for Frontline, Second-line Treatment Choices in #CLL ajmc.com/view/nccn-sess… via ajmc

Moderna and Merck’s Cancer Vaccine Cuts Risk of Recurrence or Death 44% in Late-Stage, High-Risk Melanoma After Resection $MRK AACR ajmc.com/view/moderna-a… via ajmc

TPG, AmerisourceBergen Acquire OneOncology in Deal Valued at $2.1 Billion ajmc.com/view/tpg-ameri… via ajmc

Joseph Alvarnas, MD, Discusses New CMS Drug Pricing Models, Impact for Blood Diseases City of Hope ajmc.com/view/joseph-al… via ajmc

Congrats Carlos Alcaraz 👏👏

OneOncology and TennesseeOncology experts are authors on this AJMC-Oncology article examining 5 key drivers of participation in CMS Innovation Center Enhancing Oncology Model and how CMMI could improve the low participation in this or future models. ajmc.com/view/why-eom-p…

I've been doing some freelance reporting on how manufacturing delays with CAR-Ts can lead clinicians to look for other options - one physician calls these delays a "wait list mortality" - bit.ly/49frKI0 AJMC AJMC-Oncology

Tina Basenese Astera Cancer Care, and vice chair of OneOncology's palliative care committee, authored this piece in AJMC-Oncology detailing 6 strategies to advance and scale palliative care. ⤵ Read the full article. ⤵ ajmc.com/view/scaling-p…